Abbott's US Diagnostics Sales Decline in Q2 Due to Falling COVID-19 Test Demand: GlobalData
Abbott Laboratories has continued to demonstrate steady performance in the US medical device market amid market shifts, though its diagnostics segment experienced a modest decline, according to new insights from GlobalData, a leading data and analytics firm.
COVID-19 Testing | 12/08/2025 | By Dineshwori | 110
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy